Global and Japan Systemic Sclerosis Drug Market Insights, Forecast to 2026

Global and Japan Systemic Sclerosis Drug Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Systemic Sclerosis Drug Product Introduction
1.2 Market Segments
1.3 Key Systemic Sclerosis Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Systemic Sclerosis Drug Market Size Growth Rate by Type
1.4.2 ARG-201
1.4.3 Belimumab
1.4.4 BL-1110
1.4.5 BOT-191
1.4.6 C-82
1.4.7 Others
1.5 Market by Application
1.5.1 Global Systemic Sclerosis Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 ASCs
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Systemic Sclerosis Drug Market Size, Estimates and Forecasts
2.1.1 Global Systemic Sclerosis Drug Revenue 2015-2026
2.1.2 Global Systemic Sclerosis Drug Sales 2015-2026
2.2 Global Systemic Sclerosis Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Systemic Sclerosis Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Systemic Sclerosis Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Systemic Sclerosis Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Systemic Sclerosis Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Systemic Sclerosis Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Systemic Sclerosis Drug Revenue Forecast by Region (2021-2026)
3 Global Systemic Sclerosis Drug Competitor Landscape by Players
3.1 Global Top Systemic Sclerosis Drug Sales by Manufacturers
3.1.1 Global Systemic Sclerosis Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Systemic Sclerosis Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Systemic Sclerosis Drug Manufacturers by Revenue
3.2.1 Global Systemic Sclerosis Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Systemic Sclerosis Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Systemic Sclerosis Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Systemic Sclerosis Drug Revenue in 2019
3.2.5 Global Systemic Sclerosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Systemic Sclerosis Drug Price by Manufacturers
3.4 Global Systemic Sclerosis Drug Manufacturing Base Distribution, Product Types
3.4.1 Systemic Sclerosis Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Systemic Sclerosis Drug Product Type
3.4.3 Date of International Manufacturers Enter into Systemic Sclerosis Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Systemic Sclerosis Drug Market Size by Type (2015-2020)
4.1.1 Global Systemic Sclerosis Drug Sales by Type (2015-2020)
4.1.2 Global Systemic Sclerosis Drug Revenue by Type (2015-2020)
4.1.3 Systemic Sclerosis Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Systemic Sclerosis Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Systemic Sclerosis Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Systemic Sclerosis Drug Revenue Forecast by Type (2021-2026)
4.2.3 Systemic Sclerosis Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Systemic Sclerosis Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Systemic Sclerosis Drug Market Size by Application (2015-2020)
5.1.1 Global Systemic Sclerosis Drug Sales by Application (2015-2020)
5.1.2 Global Systemic Sclerosis Drug Revenue by Application (2015-2020)
5.1.3 Systemic Sclerosis Drug Price by Application (2015-2020)
5.2 Systemic Sclerosis Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Systemic Sclerosis Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Systemic Sclerosis Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Systemic Sclerosis Drug Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Systemic Sclerosis Drug Market Size YoY Growth 2015-2026
6.1.1 Japan Systemic Sclerosis Drug Sales YoY Growth 2015-2026
6.1.2 Japan Systemic Sclerosis Drug Revenue YoY Growth 2015-2026
6.1.3 Japan Systemic Sclerosis Drug Market Share in Global Market 2015-2026
6.2 Japan Systemic Sclerosis Drug Market Size by Players (International and Local Players)
6.2.1 Japan Top Systemic Sclerosis Drug Players by Sales (2015-2020)
6.2.2 Japan Top Systemic Sclerosis Drug Players by Revenue (2015-2020)
6.3 Japan Systemic Sclerosis Drug Historic Market Review by Type (2015-2020)
6.3.1 Japan Systemic Sclerosis Drug Sales Market Share by Type (2015-2020)
6.3.2 Japan Systemic Sclerosis Drug Revenue Market Share by Type (2015-2020)
6.3.3 Japan Systemic Sclerosis Drug Price by Type (2015-2020)
6.4 Japan Systemic Sclerosis Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Systemic Sclerosis Drug Sales Forecast by Type (2021-2026)
6.4.2 Japan Systemic Sclerosis Drug Revenue Forecast by Type (2021-2026)
6.4.3 Japan Systemic Sclerosis Drug Price Forecast by Type (2021-2026)
6.5 Japan Systemic Sclerosis Drug Historic Market Review by Application (2015-2020)
6.5.1 Japan Systemic Sclerosis Drug Sales Market Share by Application (2015-2020)
6.5.2 Japan Systemic Sclerosis Drug Revenue Market Share by Application (2015-2020)
6.5.3 Japan Systemic Sclerosis Drug Price by Application (2015-2020)
6.6 Japan Systemic Sclerosis Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Systemic Sclerosis Drug Sales Forecast by Application (2021-2026)
6.6.2 Japan Systemic Sclerosis Drug Revenue Forecast by Application (2021-2026)
6.6.3 Japan Systemic Sclerosis Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America Systemic Sclerosis Drug Market Size YoY Growth 2015-2026
7.2 North America Systemic Sclerosis Drug Market Facts & Figures by Country
7.2.1 North America Systemic Sclerosis Drug Sales by Country (2015-2020)
7.2.2 North America Systemic Sclerosis Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Systemic Sclerosis Drug Market Size YoY Growth 2015-2026
8.2 Europe Systemic Sclerosis Drug Market Facts & Figures by Country
8.2.1 Europe Systemic Sclerosis Drug Sales by Country
8.2.2 Europe Systemic Sclerosis Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Systemic Sclerosis Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Systemic Sclerosis Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Systemic Sclerosis Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Systemic Sclerosis Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Systemic Sclerosis Drug Market Size YoY Growth 2015-2026
10.2 Latin America Systemic Sclerosis Drug Market Facts & Figures by Country
10.2.1 Latin America Systemic Sclerosis Drug Sales by Country
10.2.2 Latin America Systemic Sclerosis Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Systemic Sclerosis Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Systemic Sclerosis Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Systemic Sclerosis Drug Sales by Country
11.2.2 Middle East and Africa Systemic Sclerosis Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Allergan Plc
12.1.1 Allergan Plc Corporation Information
12.1.2 Allergan Plc Description and Business Overview
12.1.3 Allergan Plc Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Allergan Plc Systemic Sclerosis Drug Products Offered
12.1.5 Allergan Plc Recent Development
12.2 Angion Biomedica Corp.
12.2.1 Angion Biomedica Corp. Corporation Information
12.2.2 Angion Biomedica Corp. Description and Business Overview
12.2.3 Angion Biomedica Corp. Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Angion Biomedica Corp. Systemic Sclerosis Drug Products Offered
12.2.5 Angion Biomedica Corp. Recent Development
12.3 arGentis Pharmaceuticals, LLC
12.3.1 arGentis Pharmaceuticals, LLC Corporation Information
12.3.2 arGentis Pharmaceuticals, LLC Description and Business Overview
12.3.3 arGentis Pharmaceuticals, LLC Sales, Revenue and Gross Margin (2015-2020)
12.3.4 arGentis Pharmaceuticals, LLC Systemic Sclerosis Drug Products Offered
12.3.5 arGentis Pharmaceuticals, LLC Recent Development
12.4 Bayer AG
12.4.1 Bayer AG Corporation Information
12.4.2 Bayer AG Description and Business Overview
12.4.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Bayer AG Systemic Sclerosis Drug Products Offered
12.4.5 Bayer AG Recent Development
12.5 BioLineRx, Ltd.
12.5.1 BioLineRx, Ltd. Corporation Information
12.5.2 BioLineRx, Ltd. Description and Business Overview
12.5.3 BioLineRx, Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.5.4 BioLineRx, Ltd. Systemic Sclerosis Drug Products Offered
12.5.5 BioLineRx, Ltd. Recent Development
12.6 BiOrion Technologies B.V.
12.6.1 BiOrion Technologies B.V. Corporation Information
12.6.2 BiOrion Technologies B.V. Description and Business Overview
12.6.3 BiOrion Technologies B.V. Sales, Revenue and Gross Margin (2015-2020)
12.6.4 BiOrion Technologies B.V. Systemic Sclerosis Drug Products Offered
12.6.5 BiOrion Technologies B.V. Recent Development
12.7 Boehringer Ingelheim GmbH
12.7.1 Boehringer Ingelheim GmbH Corporation Information
12.7.2 Boehringer Ingelheim GmbH Description and Business Overview
12.7.3 Boehringer Ingelheim GmbH Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Boehringer Ingelheim GmbH Systemic Sclerosis Drug Products Offered
12.7.5 Boehringer Ingelheim GmbH Recent Development
12.8 Bristol-Myers Squibb Company
12.8.1 Bristol-Myers Squibb Company Corporation Information
12.8.2 Bristol-Myers Squibb Company Description and Business Overview
12.8.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bristol-Myers Squibb Company Systemic Sclerosis Drug Products Offered
12.8.5 Bristol-Myers Squibb Company Recent Development
12.9 Corbus pharmaceuticals, Inc.
12.9.1 Corbus pharmaceuticals, Inc. Corporation Information
12.9.2 Corbus pharmaceuticals, Inc. Description and Business Overview
12.9.3 Corbus pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Corbus pharmaceuticals, Inc. Systemic Sclerosis Drug Products Offered
12.9.5 Corbus pharmaceuticals, Inc. Recent Development
12.10 CSL Limited
12.10.1 CSL Limited Corporation Information
12.10.2 CSL Limited Description and Business Overview
12.10.3 CSL Limited Sales, Revenue and Gross Margin (2015-2020)
12.10.4 CSL Limited Systemic Sclerosis Drug Products Offered
12.10.5 CSL Limited Recent Development
12.11 Allergan Plc
12.11.1 Allergan Plc Corporation Information
12.11.2 Allergan Plc Description and Business Overview
12.11.3 Allergan Plc Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Allergan Plc Systemic Sclerosis Drug Products Offered
12.11.5 Allergan Plc Recent Development
12.12 Digna Biotech, S.L.
12.12.1 Digna Biotech, S.L. Corporation Information
12.12.2 Digna Biotech, S.L. Description and Business Overview
12.12.3 Digna Biotech, S.L. Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Digna Biotech, S.L. Products Offered
12.12.5 Digna Biotech, S.L. Recent Development
12.13 F. Hoffmann-La Roche Ltd.
12.13.1 F. Hoffmann-La Roche Ltd. Corporation Information
12.13.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
12.13.3 F. Hoffmann-La Roche Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.13.4 F. Hoffmann-La Roche Ltd. Products Offered
12.13.5 F. Hoffmann-La Roche Ltd. Recent Development
12.14 Fibrocell Science, Inc.
12.14.1 Fibrocell Science, Inc. Corporation Information
12.14.2 Fibrocell Science, Inc. Description and Business Overview
12.14.3 Fibrocell Science, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Fibrocell Science, Inc. Products Offered
12.14.5 Fibrocell Science, Inc. Recent Development
12.15 GenKyoTex S.A.
12.15.1 GenKyoTex S.A. Corporation Information
12.15.2 GenKyoTex S.A. Description and Business Overview
12.15.3 GenKyoTex S.A. Sales, Revenue and Gross Margin (2015-2020)
12.15.4 GenKyoTex S.A. Products Offered
12.15.5 GenKyoTex S.A. Recent Development
12.16 GlaxoSmithKline Plc
12.16.1 GlaxoSmithKline Plc Corporation Information
12.16.2 GlaxoSmithKline Plc Description and Business Overview
12.16.3 GlaxoSmithKline Plc Sales, Revenue and Gross Margin (2015-2020)
12.16.4 GlaxoSmithKline Plc Products Offered
12.16.5 GlaxoSmithKline Plc Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Systemic Sclerosis Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Systemic Sclerosis Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Systemic Sclerosis Drug Market Segments
Table 2. Ranking of Global Top Systemic Sclerosis Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Systemic Sclerosis Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of ARG-201
Table 5. Major Manufacturers of Belimumab
Table 6. Major Manufacturers of BL-1110
Table 7. Major Manufacturers of BOT-191
Table 8. Major Manufacturers of C-82
Table 9. Major Manufacturers of Others
Table 10. Global Systemic Sclerosis Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Systemic Sclerosis Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Systemic Sclerosis Drug Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Systemic Sclerosis Drug Sales Market Share by Regions (2015-2020)
Table 14. Global Systemic Sclerosis Drug Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Systemic Sclerosis Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 16. Global Systemic Sclerosis Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Systemic Sclerosis Drug Sales Share by Manufacturers (2015-2020)
Table 18. Global Systemic Sclerosis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Systemic Sclerosis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Systemic Sclerosis Drug as of 2019)
Table 20. Systemic Sclerosis Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Systemic Sclerosis Drug Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Systemic Sclerosis Drug Price (2015-2020) (USD/Pcs)
Table 23. Systemic Sclerosis Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Systemic Sclerosis Drug Product Type
Table 25. Date of International Manufacturers Enter into Systemic Sclerosis Drug Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Systemic Sclerosis Drug Sales by Type (2015-2020) (K Pcs)
Table 28. Global Systemic Sclerosis Drug Sales Share by Type (2015-2020)
Table 29. Global Systemic Sclerosis Drug Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Systemic Sclerosis Drug Revenue Share by Type (2015-2020)
Table 31. Systemic Sclerosis Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Systemic Sclerosis Drug Sales Share by Type (2021-2026)
Table 33. Global Systemic Sclerosis Drug Sales by Application (2015-2020) (K Pcs)
Table 34. Global Systemic Sclerosis Drug Sales Share by Application (2015-2020)
Table 35. Global Systemic Sclerosis Drug Sales Share by Application (2021-2026)
Table 36. Global Systemic Sclerosis Drug Sales Market Share Forecast by Application (2021-2026)
Table 37. Global Systemic Sclerosis Drug Revenue by Application (2015-2020) (US$ Million)
Table 38. Global Systemic Sclerosis Drug Revenue Market Share Forecast by Application (2021-2026)
Table 39. Japan Systemic Sclerosis Drug Sales (K Pcs) of Key Companies (2015-2020)
Table 40. Japan Systemic Sclerosis Drug Sales Share by Company (2015-2020)
Table 41. Japan Systemic Sclerosis Drug Revenue (US$ Million) by Company (2015-2020)
Table 42. Japan Systemic Sclerosis Drug Sales (K Pcs) by Type (2015-2020)
Table 43. Japan Systemic Sclerosis Drug Sales Share by Type (2015-2020)
Table 44. Japan Systemic Sclerosis Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 45. Japan Systemic Sclerosis Drug Price (K Pcs) by Type (2015-2020)
Table 46. Japan Systemic Sclerosis Drug Sales (K Pcs) by Type (2021-2026)
Table 47. Japan Systemic Sclerosis Drug Sales Share by Type (2021-2026)
Table 48. Japan Systemic Sclerosis Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 49. Japan Systemic Sclerosis Drug Revenue Share by Type (2021-2026)
Table 50. Japan Systemic Sclerosis Drug Price (K Pcs) by Type (2021-2026)
Table 51. Japan Systemic Sclerosis Drug Sales (K Pcs) by Application (2015-2020)
Table 52. Japan Systemic Sclerosis Drug Sales Share by Application (2015-2020)
Table 53. Japan Systemic Sclerosis Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 54. Japan Systemic Sclerosis Drug Sales (K Pcs) by Application (2021-2026)
Table 55. Japan Systemic Sclerosis Drug Sales Share by Application (2021-2026)
Table 56. Japan Systemic Sclerosis Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 57. Japan Systemic Sclerosis Drug Revenue Share by Application (2021-2026)
Table 58. North America Systemic Sclerosis Drug Sales by Country (2015-2020) (K Pcs)
Table 59. North America Systemic Sclerosis Drug Sales Market Share by Country (2015-2020)
Table 60. North America Systemic Sclerosis Drug Revenue by Country (2015-2020) (US$ Million)
Table 61. North America Systemic Sclerosis Drug Revenue Market Share by Country (2015-2020)
Table 62. Europe Systemic Sclerosis Drug Sales by Country (2015-2020) (K Pcs)
Table 63. Europe Systemic Sclerosis Drug Sales Market Share by Country (2015-2020)
Table 64. Europe Systemic Sclerosis Drug Revenue by Country (2015-2020) (US$ Million)
Table 65. Europe Systemic Sclerosis Drug Revenue Market Share by Country (2015-2020)
Table 66. Asia Pacific Systemic Sclerosis Drug Sales by Region (2015-2020) (K Pcs)
Table 67. Asia Pacific Systemic Sclerosis Drug Sales Market Share by Region (2015-2020)
Table 68. Asia Pacific Systemic Sclerosis Drug Revenue by Region (2015-2020) (US$ Million)
Table 69. Asia Pacific Systemic Sclerosis Drug Revenue Market Share by Region (2015-2020)
Table 70. Latin America Systemic Sclerosis Drug Sales by Country (2015-2020) (K Pcs)
Table 71. Latin America Systemic Sclerosis Drug Sales Market Share by Country (2015-2020)
Table 72. Latin Americaa Systemic Sclerosis Drug Revenue by Country (2015-2020) (US$ Million)
Table 73. Latin America Systemic Sclerosis Drug Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Systemic Sclerosis Drug Sales by Country (2015-2020) (K Pcs)
Table 75. Middle East and Africa Systemic Sclerosis Drug Sales Market Share by Country (2015-2020)
Table 76. Middle East and Africa Systemic Sclerosis Drug Revenue by Country (2015-2020) (US$ Million)
Table 77. Middle East and Africa Systemic Sclerosis Drug Revenue Market Share by Country (2015-2020)
Table 78. Allergan Plc Corporation Information
Table 79. Allergan Plc Description and Business Overview
Table 80. Allergan Plc Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Allergan Plc Systemic Sclerosis Drug Product
Table 82. Allergan Plc Recent Development
Table 83. Angion Biomedica Corp. Corporation Information
Table 84. Angion Biomedica Corp. Description and Business Overview
Table 85. Angion Biomedica Corp. Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Angion Biomedica Corp. Product
Table 87. Angion Biomedica Corp. Recent Development
Table 88. arGentis Pharmaceuticals, LLC Corporation Information
Table 89. arGentis Pharmaceuticals, LLC Description and Business Overview
Table 90. arGentis Pharmaceuticals, LLC Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. arGentis Pharmaceuticals, LLC Product
Table 92. arGentis Pharmaceuticals, LLC Recent Development
Table 93. Bayer AG Corporation Information
Table 94. Bayer AG Description and Business Overview
Table 95. Bayer AG Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Bayer AG Product
Table 97. Bayer AG Recent Development
Table 98. BioLineRx, Ltd. Corporation Information
Table 99. BioLineRx, Ltd. Description and Business Overview
Table 100. BioLineRx, Ltd. Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. BioLineRx, Ltd. Product
Table 102. BioLineRx, Ltd. Recent Development
Table 103. BiOrion Technologies B.V. Corporation Information
Table 104. BiOrion Technologies B.V. Description and Business Overview
Table 105. BiOrion Technologies B.V. Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. BiOrion Technologies B.V. Product
Table 107. BiOrion Technologies B.V. Recent Development
Table 108. Boehringer Ingelheim GmbH Corporation Information
Table 109. Boehringer Ingelheim GmbH Description and Business Overview
Table 110. Boehringer Ingelheim GmbH Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Boehringer Ingelheim GmbH Product
Table 112. Boehringer Ingelheim GmbH Recent Development
Table 113. Bristol-Myers Squibb Company Corporation Information
Table 114. Bristol-Myers Squibb Company Description and Business Overview
Table 115. Bristol-Myers Squibb Company Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. Bristol-Myers Squibb Company Product
Table 117. Bristol-Myers Squibb Company Recent Development
Table 118. Corbus pharmaceuticals, Inc. Corporation Information
Table 119. Corbus pharmaceuticals, Inc. Description and Business Overview
Table 120. Corbus pharmaceuticals, Inc. Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. Corbus pharmaceuticals, Inc. Product
Table 122. Corbus pharmaceuticals, Inc. Recent Development
Table 123. CSL Limited Corporation Information
Table 124. CSL Limited Description and Business Overview
Table 125. CSL Limited Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 126. CSL Limited Product
Table 127. CSL Limited Recent Development
Table 128. Daval International Limited Corporation Information
Table 129. Daval International Limited Description and Business Overview
Table 130. Daval International Limited Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 131. Daval International Limited Product
Table 132. Daval International Limited Recent Development
Table 133. Digna Biotech, S.L. Corporation Information
Table 134. Digna Biotech, S.L. Description and Business Overview
Table 135. Digna Biotech, S.L. Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 136. Digna Biotech, S.L. Product
Table 137. Digna Biotech, S.L. Recent Development
Table 138. F. Hoffmann-La Roche Ltd. Corporation Information
Table 139. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 140. F. Hoffmann-La Roche Ltd. Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 141. F. Hoffmann-La Roche Ltd. Product
Table 142. F. Hoffmann-La Roche Ltd. Recent Development
Table 143. Fibrocell Science, Inc. Corporation Information
Table 144. Fibrocell Science, Inc. Description and Business Overview
Table 145. Fibrocell Science, Inc. Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 146. Fibrocell Science, Inc. Product
Table 147. Fibrocell Science, Inc. Recent Development
Table 148. GenKyoTex S.A. Corporation Information
Table 149. GenKyoTex S.A. Description and Business Overview
Table 150. GenKyoTex S.A. Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 151. GenKyoTex S.A. Product
Table 152. GenKyoTex S.A. Recent Development
Table 153. GlaxoSmithKline Plc Corporation Information
Table 154. GlaxoSmithKline Plc Description and Business Overview
Table 155. GlaxoSmithKline Plc Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 156. GlaxoSmithKline Plc Product
Table 157. GlaxoSmithKline Plc Recent Development
Table 158. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 159. Key Challenges
Table 160. Market Risks
Table 161. Main Points Interviewed from Key Systemic Sclerosis Drug Players
Table 162. Systemic Sclerosis Drug Customers List
Table 163. Systemic Sclerosis Drug Distributors List
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Systemic Sclerosis Drug Product Picture
Figure 2. Global Systemic Sclerosis Drug Sales Market Share by Type in 2020 & 2026
Figure 3. ARG-201 Product Picture
Figure 4. Belimumab Product Picture
Figure 5. BL-1110 Product Picture
Figure 6. BOT-191 Product Picture
Figure 7. C-82 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Systemic Sclerosis Drug Sales Market Share by Application in 2020 & 2026
Figure 10. Hospital
Figure 11. Clinic
Figure 12. ASCs
Figure 13. Others
Figure 14. Systemic Sclerosis Drug Report Years Considered
Figure 15. Global Systemic Sclerosis Drug Market Size 2015-2026 (US$ Million)
Figure 16. Global Systemic Sclerosis Drug Sales 2015-2026 (K Pcs)
Figure 17. Global Systemic Sclerosis Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Systemic Sclerosis Drug Sales Market Share by Region (2015-2020)
Figure 19. Global Systemic Sclerosis Drug Sales Market Share by Region in 2019
Figure 20. Global Systemic Sclerosis Drug Revenue Market Share by Region (2015-2020)
Figure 21. Global Systemic Sclerosis Drug Revenue Market Share by Region in 2019
Figure 22. Global Systemic Sclerosis Drug Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Systemic Sclerosis Drug Revenue in 2019
Figure 24. Systemic Sclerosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Systemic Sclerosis Drug Sales Market Share by Type (2015-2020)
Figure 26. Global Systemic Sclerosis Drug Sales Market Share by Type in 2019
Figure 27. Global Systemic Sclerosis Drug Revenue Market Share by Type (2015-2020)
Figure 28. Global Systemic Sclerosis Drug Revenue Market Share by Type in 2019
Figure 29. Global Systemic Sclerosis Drug Market Share by Price Range (2015-2020)
Figure 30. Global Systemic Sclerosis Drug Sales Market Share by Application (2015-2020)
Figure 31. Global Systemic Sclerosis Drug Sales Market Share by Application in 2019
Figure 32. Global Systemic Sclerosis Drug Revenue Market Share by Application (2015-2020)
Figure 33. Global Systemic Sclerosis Drug Revenue Market Share by Application in 2019
Figure 34. Japan Systemic Sclerosis Drug Sales Growth Rate 2015-2026 (K Pcs)
Figure 35. Japan Systemic Sclerosis Drug Revenue Growth Rate 2015-2026 (US$ Million)
Figure 36. Japan Systemic Sclerosis Drug Market Share in Global Market 2015-2026
Figure 37. Japan 5 and 10 Largest Systemic Sclerosis Drug Players Market Share by Revenue in Systemic Sclerosis Drug in 2019
Figure 38. Japan Systemic Sclerosis Drug Revenue Share by Type (2015-2020)
Figure 39. Japan Systemic Sclerosis Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 40. Japan Systemic Sclerosis Drug Revenue Share by Application (2015-2020)
Figure 41. Japan Systemic Sclerosis Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 42. North America Systemic Sclerosis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. North America Systemic Sclerosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. North America Systemic Sclerosis Drug Sales Market Share by Country in 2019
Figure 45. North America Systemic Sclerosis Drug Revenue Market Share by Country in 2019
Figure 46. U.S. Systemic Sclerosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. U.S. Systemic Sclerosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Canada Systemic Sclerosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Canada Systemic Sclerosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Europe Systemic Sclerosis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 51. Europe Systemic Sclerosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 52. Europe Systemic Sclerosis Drug Sales Market Share by Country in 2019
Figure 53. Europe Systemic Sclerosis Drug Revenue Market Share by Country in 2019
Figure 54. Germany Systemic Sclerosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Germany Systemic Sclerosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. France Systemic Sclerosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. France Systemic Sclerosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. U.K. Systemic Sclerosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. U.K. Systemic Sclerosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Italy Systemic Sclerosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Systemic Sclerosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Russia Systemic Sclerosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Russia Systemic Sclerosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Asia Pacific Systemic Sclerosis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 65. Asia Pacific Systemic Sclerosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 66. Asia Pacific Systemic Sclerosis Drug Sales Market Share by Region in 2019
Figure 67. Asia Pacific Systemic Sclerosis Drug Revenue Market Share by Region in 2019
Figure 68. China Systemic Sclerosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. China Systemic Sclerosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Japan Systemic Sclerosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Japan Systemic Sclerosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. South Korea Systemic Sclerosis Drug Sales Growth Rate (2015-2020) (K Pcs)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs